<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">3921</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">NAACCR</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">18</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1920 - 1921</td>
    </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.residualTumVolPostCytoreduction<br/><br/>


<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para'>Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers.</div>
<div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div>
<div class='content chap10-para'>Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3.</div>
<div class='content chap10-para'><strong>Codes</strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>00</td>
            <td class='code-desc'>No gross residual tumor nodules</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>10</td>
            <td class='code-desc'>Residual tumor nodule(s) 1 centimeter (cm) or less<br/>
                AND neoadjuvant chemotherapy not given or unknown if given

            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>20</td>
            <td class='code-desc'>Residual tumor nodule(s) 1 cm or less<br/>
                AND neoadjuvant chemotherapy given (before surgery)

            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>30</td>
            <td class='code-desc'>Residual tumor nodule(s) greater than 1 cm<br/>
                AND neoadjuvant chemotherapy not given or unknown if given
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>40</td>
            <td class='code-desc'>Residual tumor nodule(s) greater than 1 cm<br/>
                AND neoadjuvant chemotherapy given (before surgery)
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>90</td>
            <td class='code-desc'>Macroscopic residual tumor, size not stated<br/>
                AND neoadjuvant chemotherapy not given or unknown if given
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>91</td>
            <td class='code-desc'>Macroscopic residual tumor nodule(s), size not stated<br/>
                AND neoadjuvant chemotherapy given (before surgery)
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>92</td>
            <td class='code-desc'>Procedure described as optimal debulking and size of residual tumor nodule(s) not given<br/>
                AND neoadjuvant chemotherapy not given or unknown if given
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>93</td>
            <td class='code-desc'>Procedure described as optimal debulking and size of residual tumor nodule(s) not given<br/>
                AND neoadjuvant chemotherapy given (before surgery)
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>97</td>
            <td class='code-desc'>No cytoreductive surgery performed</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>98</td>
            <td class='code-desc'>Not applicable: Information not collected for this case<br/>
                (If this item is required by your standard setter, use of code 98 will result in an edit error.)
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>99</td>
            <td class='code-desc'>Not documented in medical record<br/>
                Residual tumor status after cytoreductive surgery not assessed or unknown if assessed
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'></td>
            <td class='code-desc'></td>
        </tr>
    </table>
</div>
<div class='content chap10-para'>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</div>